Cytotoxic Activity of Deferiprone, Maltol and Related Hydroxyketones against Human Tumor Cell Lines

Anticancer Research

Volumn 24, Issue 2 B, 2004, Pages 755-762

  Yasumoto, Eiji ^a   Nakano, Kensuke ^a   Nakayachi, Tohru ^a   Morshed, Sufi Reza Md ^a   Hashimoto, Ken ^a   Kikuchi, Hirotaka ^a   Nishikawa, Hirofumi ^a   Kawase, Masami ^b   Sakagami, Hiroshi ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

Author keywords

Cytotoxic activity; Deferiprone; Hydroxyketones; Maltol; Oral tumor cells

Indexed keywords

3 METHYL 1,2 CYCLOPENTANEDIONE; CASPASE 3; CASPASE 8; CASPASE 9; DEFERIPRONE; DNA FRAGMENT; FERRIC CHLORIDE; KETOL; KOJIC ACID; MALTOL; MIMOSINE; THUJAPLICIN; TROPOLONE; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN HL 60; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SPECIFICITY; HUMAN; HUMAN CELL; MOUTH CANCER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; CHELATING AGENTS; DNA FRAGMENTATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; KETONES; MIMOSINE; MONOTERPENES; MOUTH NEOPLASMS; PYRIDONES; PYRONES; STRUCTURE-ACTIVITY RELATIONSHIP; TROPOLONE;

EID: 2442478599     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hann HWL, Stahlhut MW and Blumberg B: Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res 48: 4168-4170, 1988.
2. Tanaka T, Satoh T, Onozawa Y, Kohroki J, Itoh N, Ishidate M Jr, Muto N and Tanaka K: Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells. Cell Biol Int 23: 541-550, 1999.
3. Ido Y, Muto N, Inada A, Kohroki J, Mano M, Odani T, Itoh N, Yamamoto K and Tanaka K: Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3. Cell Prolif 32: 63-73, 1999.
4. Blatt J, Taylor SR and Kontoghiorghes GJ: Comparison of activity of deferoxamine with that of oral iron chelators against human neuroblastoma cell lines. Cancer Res 49: 2925-2927, 1989.
5. Hileti D, Panayiotodis P and Hoffbrand AV: Iron chelators induce apoptosis in proliferating cells. Br J Haematology 89: 181-187, 1995.
6. Matsumura E, Morita Y, Date T, Tsujibo H, Yasuda M, Okabe T, Ishida N and Inamori Y: Cytotoxicity of the hinokitiol-related compounds, γ-thujaplicin and β-dolabrin. Biol Pharm Bull 24: 299-302, 2001.
7. Britton RS, Leicester KL and Bacon BR: Iron toxicity and chelation therapy. Int J Hematol 76: 219-228, 2002.
8. Tam TF, Leung-Toung R, Li W, Wang Y, Karimian K and Spino M: Iron chelator research: past, present, and future. Curr Med Chem 10: 983-995, 2003.
9. Sakagami H, Jiang Y, Kusama K, Atsumi T, Ueha T, Toguchi M, Iwakura I, Satoh K, Ito H, Hatano T and Yoshida T: Cytotoxic activity of hydrolyzable tannins against human oral tumor cell lines-a possible mechanism. Phytomedicine 7: 39-47, 2000.
10. Sakagami H, Satoh K, Ohata H, Takahashi H, Yoshida H, Iida M, Kuribayashi N, Sakagami T, Momose K and Takeda M: Relationship between ascorbyl radical intensity and apoptosis-inducing activity. Anticancer Res 16: 2635-2644, 1996.
11. Hitosugi N, Hatsukari I, Ohno R, Hashimoto K, Mihara S, Mizukami S, Nakamura S, Sakagami H, Nagasaka H, Matsumoto I and Kawase M: Comparative analysis of apoptosis-inducing activity of codeine and codeinone. Anesthesiology 98: 643-650, 2003.
12. Moridani MY and O'Brien PJ: Iron complexes of deferiprone and dietary plant catechols as cytoprotective superoxide radical scavengers. Biochem Pharm 62: 1579-1585, 2001.
13. Simonart T, Degraef C, Andrei G, Mosselmans R, Hermans P, Van Vooren JP, Noel JC, Boelaert JR, Snoeck R and Heenen M: Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. J Invest Dermatol 115: 893-900, 2000.
14. Simonart T, Boelaert JR, Mosselmans R, Andrei G, Noel JC, De Clercq E and Snoeck R: Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells. Gynecol Oncol 85: 95-102, 2002.
15. Hironishi M, Kordek R, Yanagihara R and Garruto RM: Maltol (3-hydroxy-2-methyl-4-pyrone) toxicity in neuroblastoma cell lines and primary murine fetal hippocampal neuronal cultures. Neurodegeneration 5: 325-529, 1996.
16. Kim DH, Hwang J-S, Baek HS, Kim K-J, Lee BG, Chang I, Kang HH and Lee OS: Development of 5-[(3-aminopropyl) phosphinooxy]-2-(hydroxymethyl)-4H-pyran-4-one as a novel whitening agent. Chem Pharm Bull 51: 113-116, 2003.
17. Mitsumori K, Onodera H, Takahashi M, Funakoshi T, Tamura T, Yasuhara K, Takegawa K and Takahashi M: Promoting effects of kojic acid due to serum TSH elevation resulting from reduced serum thyroid hormone levels on development of thyroid proliferative lesions in rats initiated with N-bis(2-hydroxypropyl)nitrosamine. Carcinogenesis 20: 173-176, 1999.
18. Chenoufi N, Drenou B, Loreal O, Pigeon C, Brissot P and Lescoat G: Antiproliferative effect of deferiprone on the Hep G2 cell line. Biochem Pharm 56: 431-437, 1998.
19. Morita Y, Matsumura E, Okabe T, Shibata M, Sugiura M, Ohe T, Tsujibo H, Ishida N and Inamori Y: Biological activity of tropolone. Biol Pharm Bull 26: 1487-1490, 2003.
20. Miyamoto D, Endo N, Oku N, Arima Y, Suzuki T and Suzuki Y: β-Thujaplicin zinc chelate induces apoptosis in mouse high metastatic melanoma B16BL6 cells. Biol Pharm Bull 21: 1258-1262, 1998.
21. Bjeldanes LF and Chew H: Mutagenicity of 1,2-dicarbonyl compounds: maltol, kojic acid, diacetyl and related substances. Mutat Res 67: 367-371, 1979.
22. Hayashi M, Kishi M, Sofuni T and Ishidate M Jr: Micronucleus tests in mice on 39 food additives and eight miscellaneous chemicals. Food Chem Toxicol 26: 487-500, 1988.
23. Kim BS, Yoon KH, Oh HM, Choi EY, Kim SW, Han WC, Kim EA, Choi SC, Kim TH, Yun KJ, Kim EC, Lyou JH, Nah YH, Chung HT, Cha YN and Jun CD: Involvement of p38 MAP kinase during iron chelator-mediated apoptosis cell death. Cell Immunol 220: 96-106, 2002.
24. Yanagisawa-Shiota F, Sakagami H, Kuribayashi N, Iida M, Sakagami T and Takeda M: Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines. Anticancer Res 15: 259-266, 1995